Home 
Bratislava Medical Journal 2018 Bratislava Medical Journal Vol.119, No.1, p.22-27, 2018
Bratislava Medical Journal 2018 Bratislava Medical Journal Vol.119, No.1, p.22-27, 2018
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.119, No.1, p.22-27, 2018 |
||
| Title: Protective role of microRNA-221 in Parkinson’s disease | ||
| Author: L. Li, J. Xu, M. Wu, J. M. Hu | ||
| Abstract: OBJECTIVE: The present study aimed to explore the role and the underlying mechanism of miR-221 in Parkinson’s Disease. MATERIALS AND METHODS: To perform our investigation, a PD cell model was created by using 6-OHDA. Cell viability and proliferation assays, and flow cytometry analysis were performed to detect cell viability and apoptosis. The qRT-PCR and western blotting were used for gene and protein level detection. RESULTS: We found that the expression of miRNA-221 is significantly lower in 6-OHDA treated PC12 pheochromocytoma cells compared to the normal cells. The results of further analysis indicated that miR-221 mimic significantly promoted the cell viability and proliferation of PC12 cells treated with 6-OHDA. MiR-221 mimic significantly inhibited 6-OHDA-treated PC12 cells from apoptosis. These effects were eliminated by PTEN over-expression. We also revealed that PTEN was a direct target gene of miR-221. Moreover, we found miR-221 mimic significantly promoted the phosphorylation of AKT in PC12 cells treated with 6-OHDA, and over-expression of PTEN could eliminate this effect. CONCLUSIONS: MiR-221 plays a protective role in Parkinson’s Disease via regulating PC12 cell viability and apoptosis by targeting PTEN. Therefore, miR-221 may serve as a potential therapeutic target for Parkinson’s disease treatment (Fig. 3, Ref. 27). |
||
| Keywords: miRNA-221, Parkinson’s Disease, PC12 cells, 6-OHDA, PD cell models | ||
| Published online: 22-Jan-2018 | ||
| Year: 2018, Volume: 119, Issue: 1 | Page From: 22, Page To: 27 | |
| doi:10.4149/BLL_2018_005 |
||
|
|
 download file |
|